Good laws exist – but laws alone won’t fix India’s pharmaceutical production
04 April 2020
On January 23, 2020, the Union Ministry of Environment, Forests and Climate Change (MoEFCC), notified draft environmental standards for the bulk drug and pharmaceutical manufacturing industry. The proposed standards aim to limit the concentration of antibiotics and other toxins in effluents from the bulk drug manufacturing sector.
Further reading: Science The Wire
Author(s): T. Mohan
Clean Environment
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
